Cascadian Therapeutics (FRA:3O61) Cash Flow from Discontinued Operations : €0.00 Mil (TTM As of Dec. 2017)

View and export this data going back to . Start your Free Trial

What is Cascadian Therapeutics Cash Flow from Discontinued Operations?

Cash flow from discontinued operations is the cash received by a company that comes from the sale of part of business.

Cascadian Therapeutics's cash flow from discontinued operations for the three months ended in Dec. 2017 was €0.00 Mil. It means Cascadian Therapeutics received €0.00 Mil from the sale of part of business quarterly. Cascadian Therapeutics's cash flow from discontinued operations for the trailing twelve months (TTM) ended in Dec. 2017 was €0.00 Mil.

Cascadian Therapeutics Cash Flow from Discontinued Operations Historical Data

The historical data trend for Cascadian Therapeutics's Cash Flow from Discontinued Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cascadian Therapeutics Cash Flow from Discontinued Operations Chart

Cascadian Therapeutics Annual Data

Trend

Dec08

Dec09

Dec10

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Cash Flow from Discontinued Operations

Get a 7-Day Free Trial

Cascadian Therapeutics Quarterly Data
	Mar13	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17
Cash Flow from Discontinued Operations	Get a 7-Day Free Trial															-	-	-	-	-

Cascadian Therapeutics Cash Flow from Discontinued Operations Calculation

Cash received by a company that comes from the sale of part of business.

Cash Flow from Discontinued Operations for the trailing twelve months (TTM) ended in Dec. 2017 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.00 Mil.

Cascadian Therapeutics Cash Flow from Discontinued Operations Related Terms

Thank you for viewing the detailed overview of Cascadian Therapeutics's Cash Flow from Discontinued Operations provided by GuruFocus.com. Please click on the following links to see related term pages.

Cascadian Therapeutics (FRA:3O61) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cascadian Therapeutics Inc (FRA:3O61) » Definitions » Cash Flow from Discontinued Operations

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

http://www.cascadianrx.com

Cascadian Therapeutics Inc is a clinical-stage biopharmaceutical company focusing in developing innovative therapeutic product candidates for the treatment of cancer. Its objective is to discover, develop and commercialize novel compounds that have the potential to improve the lives and outcomes of cancer patients. The company's clinical-stage product candidate includes ONT-380, an orally active and selective small molecule HER2 inhibitor. In addition, it is also engaged in developing preclinical product candidates in oncology using its Checkpoint kinase 1 kinase inhibitor and protocell technology. All the business activity of the firm is functioned through the region of United States.

Cascadian Therapeutics (FRA:3O61) Headlines

No Headlines